2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide

C130H129F3N20O10S — CID 158097485

IUPAC2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide
SMILESCCCN(CCC)C(=O)C1=CN=C(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)C1.CN1C(=O)C(c2ccccc2)(c2ccc(-c3cccc(OC(F)(F)F)c3)s2)N=C1N.CN1C(=O)C(c2ccccc2)(c2cccc(CC(=O)CCCc3ccccc3)c2)N=C1N.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1C[C@H]1CCCN(C(=O)C2CC2)C1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NCCc2cccnc2)c1
InChIInChI=1S/C30H27N5O2.C27H31N5O2.C27H27N3O2.C25H28N4O2.C21H16F3N3O2S/c31-29-34-30(25-12-3-1-4-13-25,26-14-5-2-6-15-26)28(37)35(29)21-23-9-7-11-24(19-23)27(36)33-18-16-22-10-8-17-32-20-22;1-3-15-31(16-4-2)24(33)20-17-23(29-18-20)19-32-25(34)27(30-26(32)28,21-11-7-5-8-12-21)22-13-9-6-10-14-22;1-30-25(32)27(29-26(30)28,22-14-6-3-7-15-22)23-16-8-13-21(18-23)19-24(31)17-9-12-20-10-4-2-5-11-20;26-24-27-25(20-9-3-1-4-10-20,21-11-5-2-6-12-21)23(31)29(24)17-18-8-7-15-28(16-18)22(30)19-13-14-19;1-27-18(28)20(26-19(27)25,14-7-3-2-4-8-14)17-11-10-16(30-17)13-6-5-9-15(12-13)29-21(22,23)24/h1-15,17,19-20H,16,18,21H2,(H2,31,34)(H,33,36);5-14,18H,3-4,15-17,19H2,1-2H3,(H2,28,30);2-8,10-11,13-16,18H,9,12,17,19H2,1H3,(H2,28,29);1-6,9-12,18-19H,7-8,13-17H2,(H2,26,27);2-12H,1H3,(H2,25,26)/t;;;18-;/m...0./s1
InChIKeyFOVPJDSNKWGMME-UKMBNQFUSA-N
MW2220.65 g/mol
LogP18.05
Rot. Bonds34

About 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide

2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide (PubChem CID 158097485) has the molecular formula C130H129F3N20O10S and a molecular weight of 2220.65 g/mol. Its IUPAC name is 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide.

Molecular Properties

Compound Name2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide
PubChem CID158097485
Molecular FormulaC130H129F3N20O10S
Molecular Weight2220.65 g/mol
Exact Mass2218.99
IUPAC Name2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide
SMILESCCCN(CCC)C(=O)C1=CN=C(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)C1.CN1C(=O)C(c2ccccc2)(c2ccc(-c3cccc(OC(F)(F)F)c3)s2)N=C1N.CN1C(=O)C(c2ccccc2)(c2cccc(CC(=O)CCCc3ccccc3)c2)N=C1N.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1C[C@H]1CCCN(C(=O)C2CC2)C1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NCCc2cccnc2)c1
InChIInChI=1S/C30H27N5O2.C27H31N5O2.C27H27N3O2.C25H28N4O2.C21H16F3N3O2S/c31-29-34-30(25-12-3-1-4-13-25,26-14-5-2-6-15-26)28(37)35(29)21-23-9-7-11-24(19-23)27(36)33-18-16-22-10-8-17-32-20-22;1-3-15-31(16-4-2)24(33)20-17-23(29-18-20)19-32-25(34)27(30-26(32)28,21-11-7-5-8-12-21)22-13-9-6-10-14-22;1-30-25(32)27(29-26(30)28,22-14-6-3-7-15-22)23-16-8-13-21(18-23)19-24(31)17-9-12-20-10-4-2-5-11-20;26-24-27-25(20-9-3-1-4-10-20,21-11-5-2-6-12-21)23(31)29(24)17-18-8-7-15-28(16-18)22(30)19-13-14-19;1-27-18(28)20(26-19(27)25,14-7-3-2-4-8-14)17-11-10-16(30-17)13-6-5-9-15(12-13)29-21(22,23)24/h1-15,17,19-20H,16,18,21H2,(H2,31,34)(H,33,36);5-14,18H,3-4,15-17,19H2,1-2H3,(H2,28,30);2-8,10-11,13-16,18H,9,12,17,19H2,1H3,(H2,28,29);1-6,9-12,18-19H,7-8,13-17H2,(H2,26,27);2-12H,1H3,(H2,25,26)/t;;;18-;/m...0./s1
InChIKeyFOVPJDSNKWGMME-UKMBNQFUSA-N
XLogP18.05
TPSA414.72 Ų
H-Bond Donors6
H-Bond Acceptors23
Rotatable Bonds34
Heavy Atoms164
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002220.65
LogP ≤ 518.05
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1023

Analyze 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide?
The IUPAC name of 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide (CID 158097485) is 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide.
What is the SMILES notation for 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide?
The canonical SMILES for 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide is CCCN(CCC)C(=O)C1=CN=C(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)C1.CN1C(=O)C(c2ccccc2)(c2ccc(-c3cccc(OC(F)(F)F)c3)s2)N=C1N.CN1C(=O)C(c2ccccc2)(c2cccc(CC(=O)CCCc3ccccc3)c2)N=C1N.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1C[C@H]1CCCN(C(=O)C2CC2)C1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NCCc2cccnc2)c1.
What is the InChIKey of 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide?
The InChIKey is FOVPJDSNKWGMME-UKMBNQFUSA-N. The full InChI is InChI=1S/C30H27N5O2.C27H31N5O2.C27H27N3O2.C25H28N4O2.C21H16F3N3O2S/c31-29-34-30(25-12-3-1-4-13-25,26-14-5-2-6-15-26)28(37)35(29)21-23-9-7-11-24(19-23)27(36)33-18-16-22-10-8-17-32-20-22;1-3-15-31(16-4-2)24(33)20-17-23(29-18-20)19-32-25(34)27(30-26(32)28,21-11-7-5-8-12-21)22-13-9-6-10-14-22;1-30-25(32)27(29-26(30)28,22-14-6-3-7-15-22)23-16-8-13-21(18-23)19-24(31)17-9-12-20-10-4-2-5-11-20;26-24-27-25(20-9-3-1-4-10-20,21-11-5-2-6-12-21)23(31)29(24)17-18-8-7-15-28(16-18)22(30)19-13-14-19;1-27-18(28)20(26-19(27)25,14-7-3-2-4-8-14)17-11-10-16(30-17)13-6-5-9-15(12-13)29-21(22,23)24/h1-15,17,19-20H,16,18,21H2,(H2,31,34)(H,33,36);5-14,18H,3-4,15-17,19H2,1-2H3,(H2,28,30);2-8,10-11,13-16,18H,9,12,17,19H2,1H3,(H2,28,29);1-6,9-12,18-19H,7-8,13-17H2,(H2,26,27);2-12H,1H3,(H2,25,26)/t;;;18-;/m...0./s1.
What are the key properties of 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide?
2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide has a molecular weight of 2220.65 g/mol, XLogP of 18.05, 34 rotatable bonds, 6 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-3-[[(3S)-1-(cyclopropanecarbonyl)piperidin-3-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-methyl-5-[3-(2-oxo-5-phenylpentyl)phenyl]-5-phenylimidazol-4-one;2-amino-3-methyl-5-phenyl-5-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]imidazol-4-one;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropyl-3H-pyrrole-4-carboxamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-(2-pyridin-3-ylethyl)benzamide is sourced from PubChem (CID 158097485), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).